Stability of p-aminosalicylic acid solutions
Vetuschi, C.; Ragno, G.; Mazzeo, P.
Bollettino Chimico Farmaceutico 125(11): 373-378
1986
ISSN/ISBN: 0006-6648 PMID: 3593544 Document Number: 285112
Document emailed within 1 workday
Related Documents
Seydel, H.; Voigt, R. 1972: Stability of amino acid infusion solutions. 1. Stability of some amino acids in solutions Die Pharmazie 27(5): 303-312Seydel, H.; Voigt, R. 1972: Stability of amino acid infusion solutions. 3. Influence of certain factors on the stability of amino acid infusion solutions Die Pharmazie 27(10): 660-669
Seydel, H.; Voigt, R. 1972: Stability of amino acid infusion solutions. 2. Stability of amino acid mixtures in solution Die Pharmazie 27(7): 460-466
Janowiec, M.; Zwolska-Kwiek, Z.; Wiśniewska, A.; Wróblewska, H. 1977: Interaction of antitubercular agents. I. Combined action of rifampicin, isonicotinic acid hydrazide, streptomycin and para-aminosalicylic acid on the growth of strains of tubercle bacilli Pneumonologia Polska 45(6): 425-430
Thoma, K.; Struve, M. 1986: The stability of commercial adrenaline solutions. 3. the stability of adrenaline solutions Pharmaceutica Acta Helvetiae 61(3): 66-68
Marí, B.; Brullet, E.; Campo, R.; Bustamante, E.; Bombardó, J. 1999: 5-Aminosalicylic acid-induced acute pancreatitis Gastroenterologia y Hepatologia 22(1): 28-29
Trallori, G.; d'Albasio, G.; Bardazzi, G.; Bonanomi, A.G.; Amorosi, A.; Del Carlo, P.; Palli, D.; Galli, M.; Pacini, F. 1994: 5-Aminosalicylic acid in pregnancy: clinical report Italian Journal of Gastroenterology 26(2): 75-78
Jenss, H.; Weber, P.; Hartmann, F. 1990: 5-Aminosalicylic acid and its metabolite in breast milk during lactation American Journal of Gastroenterology 85(3): 331
Miroshnichenko, I.I.; Sokolova, G.B.; Mokhireva, L.V. 2009: Clinical pharmacokinetics of para-aminosalicylic acid tablets Antibiotiki i Khimioterapiia 54(1-2): 20-24
Mayer, W.; Erbe, S.; Wolf, G.; Voigt, R. 1974: The analysis and stability of various 1,4-benzodiazepines of pharmaceutical interest. 2. Ring contraction of nordiazepam and clonazepam. pH-Dependence of hydrolytic cleavage of diazepam(Faustan) and use of kinetic methods for determination of stability behavior of diazepam in solutions of the ampoules Die Pharmazie 29(10-11): 700-707
Malchow, H. 1987: Treatment of chronic inflammatory intestinal diseases with 5-aminosalicylic acid Der Internist 28(1): 14-20
Spector, R.; Lorenzo, A.V. 1973: The active transport of para-aminosalicylic acid from the cerebrospinal fluid Journal of Pharmacology and Experimental Therapeutics 185(3): 642-648
Miquel Servert, J.; Jareño Chaumel, A.; Oteo De La Vara, B.; Pérez Peña, F.; De Elio Membrado, F.J. 1978: Important metabolic disorders due to the administration of para aminosalicylic acid Revista Clinica Espanola 148(6): 631-641
Shafii, A.; Chowdhury, J.R.; Das, K.M. 1982: Absorption, enterohepatic circulation, and excretion of 5-aminosalicylic acid in rats American Journal of Gastroenterology 77(5): 297-299
Mantena, S.K.; Unnikrishnan, M.K.; Chandrasekharan, K. 2008: Radioprotection by copper and zinc complexes of 5-aminosalicylic acid: a preliminary study Journal of Environmental Pathology Toxicology and Oncology: Official Organ of the International Society for Environmental Toxicology and Cancer 27(2): 123-134
Nikolaus, S.; Fölscn, U.; Schreiber, S. 2000: Immunopharmacology of 5-aminosalicylic acid and of glucocorticoids in the therapy of inflammatory bowel disease Hepato-Gastroenterology 47(31): 71-82
Pieniaszek, H.J.; BatesTR 1975: Colorimetric determination of 5-aminosalicylic acid and its N-acetylated metabolite on urine and feces Research Communications in Chemical Pathology and Pharmacology 12(3): 571-581
Qin, W.-P.; Liang, T.-J.; Jiang, Y.-M. 2011: A chronic moderate manganism poisoning treated with sodium p-aminosalicylic acid Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 29(8): 619-620
Olthoff, U. 1975: Stability of metallibur. 3. Kinetics of metallibur stability in water solutions Die Pharmazie 30(4): 218-220
Isoda, K.; Nozawa, T.; Tezuka, M.; Ishida, I. 2014: Toxicity of 50-nm polystyrene particles co-administered to mice with acetaminophen, 5-aminosalicylic acid or tetracycline Die Pharmazie 69(9): 676-679